Resources Contact Us Home
Modified factor VIII

Image Number 4 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Method and apparatus for generating images using a color field sequential display
Restore software with aggregated view of content databases
Apparatus and methods for inventory, sale, and delivery of digitally transferable goods
Hand sign
Device chip carriers, modules, and methods of forming thereof
Breathing mask
Data unit receiver and sender control method
  Randomly Featured Patents
Laser-assisted chemical vapor deposition
Bracket for holding fishing rods or the like
Simplified rack for electronic components
Methods and compositions for detecting endometrial or ovarian cancer
Base board
Tinting and insulating screen lined with hydrophilic textile threads
Multiple cookie handling
Tunable tone control circuit and a device and method for tuning the RC constants
Polyphosphate flame retardant
Method of dry scrubbing reaction products resulting from flame burning